scispace - formally typeset
T

Thomas Wurdinger

Researcher at VU University Medical Center

Publications -  184
Citations -  16228

Thomas Wurdinger is an academic researcher from VU University Medical Center. The author has contributed to research in topics: Cancer & Glioma. The author has an hindex of 49, co-authored 170 publications receiving 13289 citations. Previous affiliations of Thomas Wurdinger include VU University Amsterdam & University of Amsterdam.

Papers
More filters
Journal ArticleDOI

The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions

TL;DR: This work identifies two distinct phases of monocyte participation after MI and proposes a model that reconciles the divergent properties of these cells in healing and identifies new therapeutic targets that can influence healing and ventricular remodeling after MI.
Journal ArticleDOI

Functional delivery of viral miRNAs via exosomes

TL;DR: These findings are consistent with miRNA-mediated gene silencing as a potential mechanism of intercellular communication between cells of the immune system that may be exploited by the persistent human γ-herpesvirus EBV.
Journal ArticleDOI

MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators

TL;DR: It is demonstrated that miR-21 regulates multiple genes associated with glioma cell apoptosis, migration, and invasiveness, including the RECK and TIMP3 genes, which are suppressors of malignancy and inhibitors of matrix metalloproteinases (MMPs).
Journal ArticleDOI

In Vivo Imaging Reveals Extracellular Vesicle-Mediated Phenocopying of Metastatic Behavior

TL;DR: It is shown that EVs released by malignant tumor cells are taken up by less malignant tumors cells located within the same and within distant tumors and that these EVs carry mRNAs involved in migration and metastasis.
Journal ArticleDOI

Overcoming the blood-brain tumor barrier for effective glioblastoma treatment

TL;DR: Methods to overcome the blood-brain tumor barrier barrier (BBTB) are provided, including osmotic blood- brain barrier disruption (BBBD), bradykinin receptor-mediated BBTB opening, inhibition of multidrug efflux transporters, receptor- mediated transport systems and physiological circumvention of the BBTB.